Diabetes: Page 10

  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip
    Q&A

    Friday Q&A: Embecta CEO talks BD spinoff, future of diabetes devices

    Dev Kurdikar spoke with MedTech Dive about developing an insulin pump for patients with Type 2 diabetes and what’s next for the firm.

    By • Nov. 18, 2022
  • A patient being examined for retinal problems related to diabetes
    Image attribution tooltip
    Courtesy of AEYE Health
    Image attribution tooltip

    AEYE Health wins FDA clearance for AI-powered eye test to expand diabetic screening

    Approval is a first step to letting primary care physicians use a hand-held camera backed by AI to diagnose potential diabetic-related sight issues.

    By • Nov. 18, 2022
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet warns Omnipod 5 insulin pump charge issue may cause fire

    Rapid sales growth at the company has come amid safety problems involving some of its devices.

    By • Nov. 17, 2022
  • A Medtronics diabetes device
    Image attribution tooltip
    Courtesy of https://news.medtronic.com/MiniMed-R-670G-Hybrid-Closed-Loop-System#assets_34137_21-122
    Image attribution tooltip

    Medtronic doubles wear time of insulin pump infusion sets

    The company calculated users of its extended-wear system will change their devices 75 fewer times, resulting in annual savings of more than $1,000.

    By • Nov. 16, 2022
  • Tandem Diabetes Control-IQ
    Image attribution tooltip
    Courtesy of Tandem Diabetes
    Image attribution tooltip

    Tandem pump, paired with Dexcom CGM, boosts blood glucose control in Type 2 diabetics

    Patients with Type 2 diabetes spent 3.6 hours per day longer in the target blood glucose range after switching to Tandem’s system, a study found.

    By • Nov. 14, 2022
  • A Lilly Tempo diabetes device
    Image attribution tooltip
    Courtesy of Eli Lilly
    Image attribution tooltip

    Lilly’s new diabetes management platform to integrate Dexcom CGM

    The launch comes seven years after the company began investing in device R&D to counter pricing pressures.

    By • Nov. 9, 2022
  • A woman lifting her shirt to expose her midriff and show a Verily Onduo CGM
    Image attribution tooltip
    Courtesy of Verily
    Image attribution tooltip

    Verily’s Onduo cut blood sugar in retrospective study of Type 2 diabetics

    Participants with high blood sugar at baseline benefited the most from Onduo, a study found.

    By • Nov. 8, 2022